Most cats show a noticeable increase in appetite within the first one to three days of starting Mirataz (transdermal mirtazapine ointment). In an owner survey, about 40% of cat owners noticed their cat eating more within 24 hours, and half saw improvement within the first week.1PubMed Central. Owner’s Perspective About the Use of Mirtazapine Transdermal Ointment in Cats—A Survey-Based Study Measurable weight gain, though, follows a slower trajectory, and certain health conditions can shift the timeline in either direction.
What to Expect in the First Few Days
Mirataz is applied to the inner surface of a cat’s ear (the pinna), where the drug absorbs through the skin. After a single application, the active ingredient mirtazapine reaches peak blood levels in roughly 16 hours, though with repeated daily dosing, peak levels can arrive as quickly as two hours after application.2Wiley Online Library. Single and multiple dose pharmacokinetics of a novel mirtazapine transdermal ointment in cats That means the very first dose acts more slowly than subsequent ones. If you applied Mirataz this morning and your cat still has no interest in food by tonight, that is completely normal. The drug has not yet reached full working levels.
By the second or third day, most cats will show some appetite response. In a pilot study of client-owned cats receiving transdermal mirtazapine, researchers documented a clear increase in appetite, rate of eating, activity level, and begging behavior at home over the first several days.3Journal of Feline Medicine and Surgery. Drug exposure and clinical effect of transdermal mirtazapine in healthy young cats: a pilot study Owners in the survey study broke down the timeline like this: roughly 4 in 10 saw appetite improvement within 24 hours, another half saw it within the first week, and about 1 in 9 did not see a change until after a full week had passed.1PubMed Central. Owner’s Perspective About the Use of Mirtazapine Transdermal Ointment in Cats—A Survey-Based Study So while the typical response is fast, a minority of cats genuinely take longer.
Appetite Versus Weight Gain: Two Different Timelines
Appetite improvement and actual weight gain do not happen on the same schedule, and it helps to keep them separate in your expectations. An increased willingness to eat can show up within a day. A measurable change on the scale takes longer because your cat has to consume enough extra calories to rebuild lost tissue and fat stores.
The pivotal clinical trial for Mirataz measured body weight over 14 days in cats with unintended weight loss from various causes. After two weeks of daily transdermal mirtazapine, cats in the treatment group gained an average of about 4% of their body weight, compared to essentially no change in the placebo group.4PubMed Central. A double‐blind, placebo‐controlled, randomized study to evaluate the weight gain drug, mirtazapine transdermal ointment, in cats with unintended weight loss For a cat weighing 4 kg (roughly 9 pounds), that is about 160 grams, or a little over five ounces. It is real and measurable, but it would not necessarily be visible to you just by looking at your cat. The point is that two weeks is a reasonable window to expect body weight to start recovering if the drug is working.
In cats with lymphoma receiving chemotherapy, a similar 14-day course of transdermal mirtazapine led to weight gain in 60% of patients, with an overall median increase of about 2%.5PubMed Central. Appetite Stimulant and Anti-Emetic Effect of Mirtazapine Transdermal Ointment in Cats Affected by Lymphoma Following Chemotherapy Administration: A Multi-Centre Retrospective Study That is a sicker population dealing with chemo-related nausea, and the fact that more than half still gained weight highlights how reliably the drug stimulates eating even when cats are feeling unwell.
Cats With Chronic Kidney Disease
Chronic kidney disease (CKD) is one of the most common reasons vets prescribe Mirataz, because appetite loss is one of the hallmarks of advancing kidney failure. The evidence here is encouraging but comes with a slightly different dosing pattern. The FDA-approved Mirataz label calls for once-daily application, but many CKD cats receive mirtazapine every other day, partly because kidney dysfunction slows the body’s clearance of the drug.
In a placebo-controlled study of CKD cats receiving compounded transdermal mirtazapine every other day for three weeks, researchers found a clear increase in weight, body condition score, appetite, rate of eating, and begging behavior.6PubMed Central. Assessment of compounded transdermal mirtazapine as an appetite stimulant in cats with chronic kidney disease The median weight gain was about 0.22 to 0.26 kg depending on the dose, compared to slight weight loss during the placebo period. So even on a less frequent dosing schedule, CKD cats can regain meaningful weight over a few weeks.
One thing to know about CKD cats: the appetite effect of the drug itself should still appear within the first few days, just as it does in other cats. What can take longer is the downstream result of weight gain, because cats with kidney disease are often dealing with nausea, dehydration, and metabolic imbalances that make calorie retention harder. If your cat with CKD is eating better but still not gaining weight after two to three weeks, your vet will likely want to re-evaluate whether the underlying disease needs more aggressive management alongside the appetite stimulant.
Why Liver Disease Changes the Timeline
Mirtazapine is processed by the liver, and liver disease significantly affects how quickly a cat’s body handles the drug. In a pharmacokinetic study comparing cats with liver disease to healthy controls, the drug’s half-life was nearly doubled in the liver disease group: about 14 hours compared to about 7 hours in healthy cats.7PubMed Central. In vivo and in vitro assessment of mirtazapine pharmacokinetics in cats with liver disease The drug also took longer to reach peak levels in these cats. Some individual cats with severe liver disease had a half-life exceeding 60 hours, meaning the drug lingered far longer than it would in a healthy animal.
What this means in practice is that cats with liver problems should be dosed less frequently, and their response timeline looks different. The drug reaches peak effect more slowly, so appetite improvement might take a bit longer to appear. On the flip side, the drug also clears more slowly, which means side effects can be more pronounced and last longer. Your vet will typically adjust the dosing interval based on the severity of the liver disease. If your cat has liver issues and is starting Mirataz, do not be surprised if the vet prescribes it every two or three days rather than daily, and do not expect the same overnight appetite boost that healthy cats sometimes show.
Side Effects and When They Appear
Side effects from Mirataz at normal doses are generally mild, but it helps to know what they look like so you can distinguish them from symptoms of your cat’s underlying illness. The most commonly reported behavioral changes at therapeutic doses include increased vocalization (some cats become very chatty) and occasional restlessness or agitation. A study of CKD cats on transdermal mirtazapine noted that while the group as a whole did not show a statistically significant change in vocalization or activity, some individual cats did become excessively vocal.6PubMed Central. Assessment of compounded transdermal mirtazapine as an appetite stimulant in cats with chronic kidney disease This is often mild and self-limiting, but it can be startling the first time you hear your normally quiet cat yowling at 2 a.m.
Local skin irritation at the application site can also occur. You are applying the ointment to the inner ear flap, which is thin and sensitive skin. Mild redness or flaking is occasionally reported. Alternating ears with each application can help reduce this.
Most side effects, when they happen at normal doses, show up within the first day or two of treatment. If your cat tolerates the drug well through the first few applications, new side effects are unlikely to emerge later unless the dosing changes.
What Mirtazapine Toxicity Looks Like
Overdose is a separate concern from normal side effects, and it tends to happen either when cats get into oral mirtazapine tablets meant for humans or when dosing errors occur. A retrospective study of 84 cats exposed to toxic doses of mirtazapine found that the most common signs were vocalization (in about 56% of cases), agitation (31%), vomiting (26%), abnormal gait (17%), restlessness and tremors (each about 14%), and excessive drooling (13%).8PubMed Central. Mirtazapine toxicity in cats: retrospective study of 84 cases (2006–2011) Signs appeared within 15 minutes to 3 hours after exposure and typically resolved within 12 to 48 hours.
The average toxic dose in those cases was well above what Mirataz delivers transdermally. Mirataz is dosed at 2 mg per cat, while the toxic exposures in that study averaged around 2.5 mg per kilogram of body weight, which for a typical cat would be 10 mg or more. Still, if you accidentally apply too much ointment, or if your cat licks the application site before it dries, or if another cat in the household grooms the treated cat’s ear, you should contact your vet or the ASPCA Animal Poison Control Center. The transdermal route delivers the drug more slowly than oral ingestion, so accidental double-application is less dangerous than swallowing a tablet, but it still warrants a call.
When It Does Not Seem to Be Working
If your cat has been on Mirataz for a week with no visible change in appetite, there are a few things worth considering before concluding the drug has failed.
- Application technique: Mirataz needs to contact the bare skin on the inner ear flap. If the ointment ends up on fur, or if your cat shakes it off or paws at the ear right after application, much less drug is actually absorbed. Wearing gloves, applying a thin ribbon of ointment, and gently holding the ear closed for a few seconds after application can improve absorption.
- Underlying nausea: Mirtazapine does have some anti-nausea properties, but it is primarily an appetite stimulant. If a cat is profoundly nauseated from kidney disease, pancreatitis, or chemotherapy, the appetite signal the drug sends may be overridden by the nausea signal. Your vet might add a dedicated anti-nausea medication alongside Mirataz.
- Severe illness: In very sick cats, appetite stimulation alone cannot overcome the metabolic storm of advanced organ failure or cancer. Mirataz works best when the underlying condition is at least partially managed.
- Pain: Cats in pain, particularly oral pain from dental disease or stomatitis, may want to eat but refuse because eating hurts. Mirataz cannot fix that. If your cat approaches food eagerly but then backs away, pain rather than lack of appetite may be the issue.
About 11% of owners in the survey study reported that their cat did not show appetite improvement until after the first full week, so patience is sometimes warranted.1PubMed Central. Owner’s Perspective About the Use of Mirtazapine Transdermal Ointment in Cats—A Survey-Based Study But if two weeks have passed with no change at all, it is reasonable to discuss alternatives with your vet.
Mirataz Versus Compounded Transdermal Mirtazapine
You may hear your vet mention compounded mirtazapine as an alternative to the brand-name Mirataz product. Compounding pharmacies can prepare transdermal mirtazapine in a gel or PLO (pluronic lecithin organogel) base, often at a lower price. The drug itself is the same, but the delivery vehicle and the consistency of dosing can differ.
Mirataz was the first FDA-approved transdermal mirtazapine product for cats, and the pharmacokinetic data behind its approval showed predictable absorption and consistent blood levels with daily use.2Wiley Online Library. Single and multiple dose pharmacokinetics of a novel mirtazapine transdermal ointment in cats Compounded formulations have also been studied and shown to be effective, particularly in CKD cats where every-other-day dosing at either 1.88 mg or 3.75 mg produced significant weight gain and appetite improvement over three weeks.6PubMed Central. Assessment of compounded transdermal mirtazapine as an appetite stimulant in cats with chronic kidney disease The practical difference is that compounded products are not subject to the same FDA manufacturing controls, so the actual amount of drug delivered per application can vary between batches. Whether that variation matters clinically is debatable, but it is something to be aware of if your cat responds well to one refill and not as well to another.
The onset of action should be similar between Mirataz and compounded transdermal mirtazapine, assuming the compounded product delivers an adequate dose. If your cat has been switched from one to the other and the response seems different, absorption differences are a plausible explanation.
How Oral Mirtazapine Compares
Before the transdermal ointment existed, mirtazapine was given to cats as an oral tablet, typically a quarter of a 15 mg human tablet. The oral route delivers the drug more quickly to the bloodstream, with a shorter time to peak levels. Pharmacokinetic work in healthy young cats found oral mirtazapine had a median half-life of roughly 9 to 16 hours depending on dose, with no drug accumulation detected over six days of daily administration at the lower dose.9Wiley Online Library. Studies on the pharmacokinetics and pharmacodynamics of mirtazapine in healthy young cats
The main advantage of the transdermal version is obvious to anyone who has tried to pill a sick cat: you do not have to open your cat’s mouth. For cats who are already nauseated or who have painful oral conditions, forcing a pill can trigger vomiting, stress, and a worsening aversion to food. The transdermal route avoids all of that. The tradeoff is slightly slower initial absorption, as reflected in the longer time to peak blood levels after a single application. But once you are a few days into daily use, the pharmacokinetic gap narrows considerably and blood levels stabilize.
If speed of onset is critical, such as in an emergency inpatient setting where a cat needs to eat right now, some vets will give the first dose orally and then switch to Mirataz for ongoing home use. This is an off-label approach, and it makes sense only for specific clinical scenarios. For routine outpatient use, starting with Mirataz and waiting a day or two for full effect is the standard recommendation.
Managing Expectations Over Weeks and Months
Mirataz is typically prescribed for a defined course rather than indefinitely. The pivotal trial ran 14 days, and many vets use a two- to four-week course as a starting point, reassessing at the end. Some cats, particularly those with chronic conditions like CKD or inflammatory bowel disease, end up on long-term or intermittent mirtazapine. In those cases, the appetite-stimulating effect does appear to persist over weeks, as demonstrated in the three-week CKD trial where benefits remained consistent throughout.6PubMed Central. Assessment of compounded transdermal mirtazapine as an appetite stimulant in cats with chronic kidney disease
Whether tolerance develops over months of continuous use is less well studied. Anecdotally, some owners and vets report that the appetite effect can wane after prolonged daily use, prompting a switch to every-other-day dosing or a brief drug holiday. If you notice your cat’s appetite fading again after initially responding well, this is a conversation worth having with your vet rather than adjusting the dose on your own. Mirtazapine has serotonergic activity, and abrupt changes in dosing can occasionally cause rebound effects. A gradual approach to any changes is the safest bet.